[19] [20] However, existing NICE guidance on the management of obesity and type 2 diabetes including guidance on approved GLP-1 receptor agonists provides a relevant framework for understanding how such agents are evaluated and monitored within the NHS
For example, medications like Semaglutide and Tirzepatide, with their once-weekly dosing regimens, may have prolonged effects on gastric emptying of uncertain duration that persist beyond the medications active window, raising questions about the timing of preoperative fasting and the management of gastric residuals (Almandoz et al
This ingredient works by imitating a natural hormone in the body that controls appetite, i.e., Ghrelin
Nat Chem Biol 10:917 Hwang C, Sinskey AJ, Lodish HF (1992) Oxidized redox state of glutathione in the endoplasmic reticulum
While gastrointestinal symptoms dominate the adverse effect profile, patients and clinicians have increasingly questioned whether these medications might contribute to musculoskeletal complaints, including muscle pain, weakness, or discomfort
Int J Mol Sci (2022) 23(2):739
